Record setting volume day!
Statera Biopharma (STAB) reported earnings of $0.62 per diluted share in fiscal Q1, compared with $0.08 a year earlier.
The engineering services company also reported revenue of just under $82 million, up from $44.5 million a year ago. Shares were up 112% by Thursday afternoon as trading volume catapulted to more than 182.1 million versus its daily average of roughly 3.66 million.
